Use of counterfeit Ozempic linked to hypoglycemia
Suspected counterfeit versions of Novo Nordisk’s diabetes drug Ozempic have led to critically low blood sugar levels, hypoglycemia, in several patients in the US.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
UK issues warning about counterfeit Novo Nordisk medicines
For subscribers